DJIA 17,131.29 60.07 0.35%
NASDAQ 4,516.41 10.56 0.23%
S&P 500 1,983.16 5.36 0.27%
market minute promo

Sanofi (ADR) (NYSE: SNY)



company name or ticker
Company Photos
(Click to zoom)

Sanofi Reports Positive Phase III Data on Dengue Vaccine - Analyst Blog

Sanofi Reports Positive Phase III Data on Dengue Vaccine - Analyst Blog

Regeneron/Sanofi Presents Encouraging Alirocumab Data - Analyst Blog

Sanofi Should Be Part Of Your Portfolio If You Want Higher Returns

Why Jim Cramer Likes Regeneron (REGN) Stock Over Sanofi (SNY)

Is It Time to Buy Pfizer Inc.'s Stock?

Pfizer stock has more than doubled since the recession lows. Can its shares head even higher or should investors be looking to lock in their gains?

Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM

How Will Regeneron Pharmaceuticals (REGN) Stock Be Affected By This Coverage?

Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri

Regeneron Pharmaceuticals and Sanofi's PCSK9 drug, alirocumab, reduces cardiovascular events, but the data come from a post-hoc analysis.

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Amgen Submits Regulatory Application for PCSK9 Inhibitor - Analyst Blog

See More Articles...